Paper33332228
A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy.
Stabile E and 37 others. Vasc Med, 2021. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy. Papers, record 33332228. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33332228
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Extremities | Major topic |
| Hospitalization | Major topic |
| Ischemia | Major topic |
| SARS-CoV-2 | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Chronic Disease | |
| Cross-Sectional Studies | |
| Female | |
| Humans | |
| Italy | |
| Male | |
| Middle Aged | |
| Peripheral Arterial Disease | |
| Retrospective Studies | |
| Risk Factors |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27692726 | Critical Limb Ischemia: An Expert Statement. | J Am Coll Cardiol | 2016 | https://conductscience.org/library/papers/27692726 | PubMed |
| 2 | 33405234 | Global impact of the first coronavirus disease 2019 (COVID-19) pandemic wave on vascular services. | Br J Surg | 2020 | https://conductscience.org/library/papers/33405234 | PubMed |
| 3 | 31308682 | The burden of critical limb ischemia: a review of recent literature. | Vasc Health Risk Manag | 2019 | https://conductscience.org/library/papers/31308682 | PubMed |
| 4 | 32283124 | Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. | J Am Coll Cardiol | 2020 | https://conductscience.org/library/papers/32283124 | PubMed |
| 5 | 32182130 | Be Prepared. | Circ Cardiovasc Qual Outcomes | 2020 | https://conductscience.org/library/papers/32182130 | PubMed |
| 6 | 32182131 | Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. | Circ Cardiovasc Qual Outcomes | 2020 | https://conductscience.org/library/papers/32182131 | PubMed |
| 7 | 32360372 | An increased severity of peripheral arterial disease in the COVID-19 era. | J Vasc Surg | 2020 | https://conductscience.org/library/papers/32360372 | PubMed |
| 8 | 28886620 | 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). | Eur Heart J | 2018 | https://conductscience.org/library/papers/28886620 | PubMed |
| 9 | 32540921 | Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes. | Diabetes Care | 2020 | https://conductscience.org/library/papers/32540921 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39353960 | Impact of the COVID-19 pandemic on patients with peripheral arterial disease in China: a multicenter cross-sectional study. | Sci Rep | 2024 | https://conductscience.org/library/papers/39353960 | PubMed |
| 37435114 | Distinct Features of Vascular Diseases in COVID-19. | J Inflamm Res | 2023 | https://conductscience.org/library/papers/37435114 | PubMed |
| 36958904 | A review of disparities in peripheral artery disease and diabetes-related amputations during the COVID-19 pandemic. | Semin Vasc Surg | 2023 | https://conductscience.org/library/papers/36958904 | PubMed |
| 36292256 | Peripheral Artery Disease Causes More Harm to Patients than COVID-19. | Healthcare (Basel) | 2022 | https://conductscience.org/library/papers/36292256 | PubMed |
| 35677745 | Impact of COVID-19 on the surgical profile of vascular surgery patients at a tertiary hospital in Curitiba, Brazil. | J Vasc Bras | 2022 | https://conductscience.org/library/papers/35677745 | PubMed |
| 34833121 | Cardiovascular Surgical Emergencies in France, before, during and after the First Lockdown for COVID-19 in 2020: A Comparative Nationwide Retrospective Cohort Study. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34833121 | PubMed |
| 34713947 | The impact of the SARS-CoV-2 pandemic on the management of chronic limb-threatening ischemia and wound care. | Wound Repair Regen | 2022 | https://conductscience.org/library/papers/34713947 | PubMed |
| 34642041 | Influence of the COVID-19 pandemic on the management of chronic limb-threatening ischemia. | Semin Vasc Surg | 2021 | https://conductscience.org/library/papers/34642041 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33332228
GET https://conductscience.org/api/papers/v1/33332228/authors?page=2